21028 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
Treatment Of IgE-Mediated Diseases With Antibodies That Specifically Bind CD38
#302PARAPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITION ADMINISTRABLE TO A LIVING BEING, PREFERABLY A HUMAN BEING, COMPRISING AT LEAST ONE ENZYME FOR THE TREATMENT AND/OR PREVENTION OF BACTERIAL INFECTIONS INVOLVING BIOFILM FORMATION
#303VISCOSITY-REDUCING EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#304FORMULATIONS COMPRISING GLUCOCEREBROSIDASE AND ISOFAGOMINE
#305ENGINEERED PROBIOTICS FOR EXPRESSION OF FIBER-SYNTHESIZING ENZYMES IN GUT
#306STABLE FORMULATIONS OF PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND HYALURONIDASE VARIANTS AND FRAGMENTS THEREOF AND METHODS OF USE THEREOF
#307COMPOSITIONS AND METHODS FOR TREATING SERRATED COLORECTAL CANCER
#308PH20 polypeptide variants, formulations and uses thereof
#309Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses
#310USE OF ISOTHIOCYANATE IN SMOKELESS TOBACCO PRODUCTS
#311ANTI-TFR:GAA AND ANTI-CD63:GAA INSERTION FOR TREATMENT OF POMPE DISEASE
#312COACTIVE COMBINATIONS OF ANTIMICROBIALS WITH DISPERSINB
#313Controlled entrapment and release of molecular cargo
#314Lipid nanoparticle compositions and methods for mRNA delivery
#315Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and Dexamethasone
#316METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISEASE
#317METHODS AND COMPOSITIONS FOR TRANSDUCING HEMATOPOIETIC STEM AND PROGENITOR CELLS IN VIVO
#318ENHANCEMENT OF CARTILAGE REGENERATIVE ACTIVITY OF STEM CELL POPULATIONS BASED ON REDUCTION OF INTRA-ARTICULAR CELLULAR MATERIAL
#319IMMUNE CELL DELIVERY OF SIALIDASE CANCER CELLS, IMMUNE CELLS AND THE TUMOR MICROENVIRONMENT
#320POLYNUCLEOTIDES ENCODING ALPHA-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE
#321SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
#322IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF
#323Use of Amylase or Maltose to Treat or Prevent Neurodegeneration
#324HYALURONIDASE FUSION PROTEINS COMPRISING A TARGETING SEQUENCE AND METHODS OF USING SAME TO TREAT A COSMETIC CONDITION
#325PH20 polypeptide variants, formulations and uses thereof
#326PH20 polypeptide variants, formulations and uses thereof
#327Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and Dexamethasone
#328LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#329PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF
#330A GENETICALLY MODIFIED CELL LINE PRODUCING A RECOMBINANT GLYCOPROTEIN HAVING A MANNOSE-TERMINATED N-GLYCAN
#331Lipid nanoparticle compositions and methods for MRNA delivery
#332Lipid nanoparticle compositions and methods for MRNA delivery
#333CONJUGATES OF BIOLOGICALLY ACTIVE MOLECULES TO FUNCTIONALIZED POLYMERS
#334MATERIALS AND METHODS FOR MITIGATING IMMUNE-SENSITIZATION
#335B-GLUCURONIDASE PROTEINS HAVING PNEUMOCOCCAL CAPSULE DEGRADING ACTIVITY AND METHODS OF USE
#336Methods and compositions for the treatment of steatosis-associated disorders
#337Methods and Compositions for the Treatment of Steatosis-Associated Disorders
#338MANUFACTURING OF SYNTHETIC EXOSOMES FOR CNS AND NON-CNS DELIVERY OF THERAPEUTICS
#339Adeno-associated virus variant capsids and methods of use thereof
#340VIRAL PARTICLES FOR USE IN TREATING TAUOPATHIES SUCH AS ALZHEIMER'S DISEASES BY GENE THERAPY
#341Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and Prednisone
#342PHARMACEUTICAL COMPOSITION OF ENZYMES AND VIRUSES AND APPLICATION THEREOF
#343MODIFIED PlySs2 LYSINS AND ANTIBIOTIC COMBINATIONS FOR USE AGAINST GRAM-POSITIVE BACTERIA
#344BIOFILM PREVENTION, DISRUPTION AND TREATMENT WITH BACTERIOPHAGE LYSIN
#345Implantable device for sustained release of a macromolecular drug compound
#346EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#347COMPOSITIONS AND METHODS COMPRISING LYSIN PLYCP025 AND DERIVATIVES THEREOF
#348COMPOSITIONS AND METHODS FOR TREATING LATE-ONSET POMPE DISEASE
#349PH20 polypeptide variants, formulations and uses thereof
#350COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS
#351Lysosomal Targeting Peptides and Uses Thereof
#352COMPOSITIONS AND METHODS FOR INHIBITING BIOFILM DEPOSITION AND PRODUCTION
#353Polypeptides that bind complement component C5 or serum albumin and fusion proteins thereof
#354Use of Approved Anti-CD38 Antibody Drug Product in Combination with Pomalidomide and Dexamethasone to Treat Multiple Myeloma
#355ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM
#356METHODS AND COMPOSITIONS FOR TREATING CYTOKINE STORM, ARDS, AND ACUTE LUNG INJURY USING BETA-GLUCOCEREBROSIDASE
#357Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins
#358PH20 polypeptide variants, formulations and uses thereof
#359CONDITIONING REGIMEN FOR TRANSPLANT
#360Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins
#361Immunomodulating Gene Therapy
#362CRISPR-MEDIATED GENOME EDITING WITH VECTORS
#363EFFICIENT AQUEOUS ENCAPSULATION AND CONTROLLED RELEASE OF BIOACTIVE AGENTS
#364Subcutaneously administered anti-IL-6 receptor antibody
#365METHODS FOR ENHANCING ADOPTIVE CELL TRANSFER IMMUNOTHERAPIES
#366THERAPEUTIC AND PROPHYLACTIC TREATMENT FOR COLORECTAL CANCER
#367A NEW PROCESS OF PURIFICATION OF PROTEINS FROM HEN EGG WHITE AND THE USE OF THE SAME AS ANTIVIRAL AGENT AGAINST SARS-COV-2
#368COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE
#369AEROSOLIZED HYALURONIDASE AND/OR 4-METHYLUMBELLIFERONE COMPOSITIONS AND METHODS OF USING SAME TO TREAT RESPIRATORY DISEASES OR DISORDERS
#370Manipulating Glycogen in Alzheimer’s Disease, Epilepsy, Traumatic Brain Injury, and ALS as a Treatment
#371STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA
#372CNS DELIVERY OF THERAPEUTIC AGENTS
#373Method for Treating Tissue
#374DRUG, FOOD AND APPLICATION OF ANTI-CORONAVIRUS INFECTION
#375Recombinant Alpha-Galactosidase A For Treatment Of Fabry Disease
#376USE OF CD83 IN COMBINATION THERAPIES
#377EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
#378PH20 polypeptide variants, formulations and uses thereof
#379METHOD OF TREATING GENE THERAPY ASSOCIATED TOXICITY WITH ANTIBIOTICS
#380COMPOUND NUTRIENT CAPABLE OF REPAIRING DAMAGED INTESTINES OF PIGELETS AND METHOD OF USING THE SAME
#381ADENO-ASSOCIATED VIRUS VECTORS ENCODING MODIFIED G6PC AND USES THEREOF
#382ORAL TERPENE CYCLODEXTRIN INCLUSION COMPLEX VEHICLES
#383COMBINATION THERAPY FOR TREATING MPS1
#384EGG PROTEIN FORMULATIONS AND METHODS OF MANUFACTURE THEREOF
#385COMBINED ANIMAL-DERIVED AND SYNTHETICALLY PRODUCED PANCREATIC ENZYME REPLACEMENT THERAPY
#386Pharmaceutical Composition for Treating Cancer Comprising Trypsinogen and/or Chymotrypsinogen and an Active Agent Selected from a Selenium Compound, a Vanilloid Compound and a Cytoplasmic Glycolysis Reduction Agent
#387Corticosteriod Reduction in Treatment with Anti-CD38 Antibody
#388NON-VIRAL DNA VECTORS AND USES THEREOF FOR EXPRESSING GAUCHER THERAPEUTICS
#389MULTI CHAMBER SYRINGE UNIT AND METHOD OF PREPARING A MULTI CHAMBER SYRINGE
#390NANOPARTICLES ENCAPSULATING SOLUBLE BIOLOGICS, THERAPEUTICS, AND IMAGING AGENTS
#391METHODS FOR TREATING FARBER DISEASE
#392COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS
#393COMPOSITIONS AND METHODS FOR TREATING PANCREATIC ENZYME DEFICIENCIES IN MAMMALS
#394COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS
#395METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES
#396VECTOR FOR CANCER TREATMENT
#397HETEROARYL COMPOUNDS AND THERAPEUTIC USES THEREOF IN CONDITIONS ASSOCIATED WITH THE ALTERATION OF THE ACTIVITY OF BETA-GLUCOCEREBROSIDASE
#398COMPOSITIONS AND METHODS FOR THE TREATMENT OF INTRACELLULAR BACTERIAL INFECTIONS
#399COMPOSITIONS AND METHODS FOR TREATING DISORDERS CHARACTERIZED WITH EXCESSIVE OSTEOCLAST ACTIVITY
#400Subcutaneous HER2 antibody formulations
#401CANCER TREATMENT
#402NOVEL COMBINATION OF NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USES THEREOF
#403INJECTABLE HIGH CONCENTRATION PHARMACEUTICAL FORMULATIONS AND METHODS OF MANUFACTURING AND USE THEREOF
#404METHODS AND COMPOSITIONS TO PREVENT AND TREAT INFLAMMATION AND ALLERGIC REACTIONS
#405PROBIOTIC COMPOSITION TO REDUCE PATHOGENESIS IN POULTRY AND METHODS FOR USE THEREOF
#406ENGINEERED TARGET SPECIFIC NUCLEASES
#407EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING
#408SUBCUTANEOUS DELIVERY OF MESSENGER RNA
#409Nanosystems for controlled transport of active molecules for diagnostic, prognostic and therapeutic purposes
#410LYSIN POLYPEPTIDES ACTIVE AGAINST GRAM-NEGATIVE BACTERIA
#411COMBINED MULTISTAGE MICROBIAL PREPARATIONS AND METHOD OF THEIR APPLICATION
#412COMPOSITIONS USEFUL FOR TREATING GM1 GANGLIOSIDOSIS
#413METHODS PROVIDING A THERAPEUTIC MACROMOLECULE AND SYNTHETIC NANOCARRIERS COMPRISING IMMUNOSUPPRESSANT LOCALLY AND CONCOMITANTLY TO REDUCE BOTH TYPE 1 AND TYPE IV HYPERSENSITIVITY
#414Viscosity-reducing excipient compounds for protein formulations
#415EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS
#416Methods and compositions for CNS delivery of iduronate-2-sulfatase
#417Conjugates of tumor necrosis factor inhibitors to functionalized polymers
#418HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT PERI-ORBITAL HOLLOWNESS AND TEAR THROUGH DEFORMITIES
#419Compositions and methods for treatment of GCase related disease states
#420Anti-CD28 Humanized Antibodies Formulated for Administration to Humans
#421METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)
#422EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#423Antimicrobial hevamine A-related compositions and methods
#424POLYMERIC NANOPARTICLES FOR INTRACELLULAR PROTEIN DELIVERY
#425HEVAMINE-RELATED PLANT COMPOSITIONS AND METHODS
#426Compositions for gut health
#427GLYCOGEN OR POLYSACCHARIDE STORAGE DISEASE TREATMENT METHOD
#428SIALIDASE-HER2-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF
#429Polypeptides and antibiotics against gram-negative bacterium comprising the same
#430COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISORDERS
#431TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS INFECTION WITH KLOTHO
#432Nanoparticles for preventing peri/post-menopausal bone loss and/or obesity
#433METHOD OF TREATING INFECTIONS BY BACTERIOLYTIC ENZYMES AND MANUFACTURE THEREOF
#434Lipid nanoparticle compositions and methods for mRNA delivery
#435A composition for boosting the immune system
#436Method and carrier complexes for delivering molecules to cells
#437COMBINATION THERAPY WITH A HYALURONAN-DEGRADING ENZYME AND AN IMMUNE CHECKPOINT INHIBITOR
#438AUGMENTED ACID ALPHA-GLUCOSIDASE FOR THE TREATMENT OF POMPE DISEASE
#439LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#440WIDE-SPECTRUM ANTIBACTERIAL PHARMACEUTICAL FORMULATIONS COMPRISING LYSOZYME AND METHODS OF USING THE SAME
#441DRUG COMBINATION FOR PREVENTING OR TREATING IRRITABLE BOWEL SYNDROME
#442Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
#443RECOMBINANT SIALIDASES AND METHODS OF USING THE SAME
#444Use of Hsp70 as a regulator of enzymatic activity
#445Lysosomal Targeting Peptides and Uses Thereof
#446Polypeptide, fusion polypeptide, and antibiotic against gram-negative bacteria comprising same
#447METHODS OF PERMITTING A SUBJECT TO RECEIVE MULTIPLE DOSES OF RECOMBINANT ADENO-ASSOCIATED VIRUS
#448HIGH CONCENTRATION ALPHA-GLUCOSIDASE COMPOSITIONS FOR THE TREATMENT OF POMPE DISEASE
#449RECOMBINANT VACCINIA VIRUS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
#450ENZYME DELIVERY SYSTEMS AND METHODS OF PREPARATION AND USE
#451MODULATION OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE LIGASE 1 (UCHL1) EXPRESSION FOR TREATING NEUROLOGICAL DISEASE, DISORDERS, AND INJURIES ASSOCIATED WITH UPPER MOTOR NEURONS
#452TREATMENT OF GLYCOGEN STORAGE DISEASE (GSD)
#453GLUCOCEREBROSIDASE MUTANTS
#454POLYSACCHARIDE-PEPTIDE COMPLEX FOR LOWERING BLOOD SUGAR, BLOOD LIPID AND GLYCOSYLATED HEMOGLOBIN LEVELS, AND PREPARATION METHOD
#455DIETARY SUPPLEMENT TO PROMOTE GUT HEALTH
#456Method for treating tissue
#457COMPOSITIONS AND METHODS USING NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
#458NK-lysin peptide compositions and methods for their use as antimicrobial/antiviral agents
#459MEDICAMENT AND FOOD FOR PREVENTING OR TREATING NOVEL CORONAVIRUS PNEUMONIA COVID-19 AND USE THEREOF
#460Cosmetic Compositions for Skin Health and Methods of Using Same
#461Method for killing bacteria with an engineered postbiotic
#462Compositions and methods for promoting a healthy microbial flora in a mammal
#463Subcutaneously administered anti-IL-6 receptor antibody
#464METHOD FOR THE MANUFACTURE OF A DOSAGE FORM WITH MUCOADHESIVE PROPERTIES FOR BUCCAL ADMINISTRATION OF BIOLOGICS
#465Use of Approved Anti-CD38 Antibody Drug Product to Treat Light Chain Amyloidosis
#466METHODS OF TREATING CELIAC DISEASE
#467METHODS OF TREATING POMPE DISEASE
#468COMPOSITIONS, DEVICES, AND METHODS FOR TREATING FABRY DISEASE
#469COMPOSITION FOR PREVENTING OR TREATING URIC ACID-RELATED DISEASE
#470Devices and methods for the preparation of a nutritional formula
#471PHARMACEUTICAL COMPOSITION CONTAINING LYSOZYME AND USE THEREOF
#472Controlled-release and stratified cyclodextrin inclusion complex vehicles
#473NANOVESICLES
#474Adeno-associated virus variant capsids and methods of use thereof
#475COMPOSITIONS AND METHODS FOR INHIBITING BIOLFILM DEPOSITION AND PRODUCTION
#476ANTICANCER COMBINATIONS
#477POLYPEPTIDES FOR TREATMENT OF BACTERIAL INFECTIONS
#478Antibody Compositions and Methods of Use Thereof
#479METHODS OF TREATING TUMORS
#480Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use
#481TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS
#482ANTIBACTERIAL COMPOSITION
#483IMPROVED DELIVERY OF GENE THERAPY VECTORS TO RETINAL CELLS USING A GLYCOSIDE HYDROLASE ENZYME
#484Chimeric endolysin LYS109 with antimicrobial activity against
#485METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
#486COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
#487INTRANASAL ADMINISTRATION OF ADENO-ASSOCIATED VIRUS TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS
#488LACTATE RESPONSE SYSTEM AND METHODS
#489RANDOM COPOLYMER STABILIZED NANOPARTICLES ENCAPSULATING SOLUBLE HYDROPHILIC COMPOUNDS
#490OLIGOSACCHARIDES COMPRISING AN AMINOOXY GROUP AND CONJUGATES THEREOF
#491DEPOLYMERASE CAPABLE OF DEGRADING EXTRACELLULAR POLYMERIC SUBSTANCES OF KLEBSIELLA PNEUMONIAE
#492COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING GLYCOGEN STORAGE DISEASE TYPE III
#493SIALYLATED GLYCOPROTEIN COMPOSITONS AND USES THEREOF
#494Cleavable lipids
#495FIBROUS MAIZE-BASED ANIMAL FEED WITH GH30 GLUCURONOXYLAN HYDROLASE
#496Compositions and methods for internalizing enzymes
#497COMPOSITIONS USEFUL FOR TREATMENT OF POMPE DISEASE
#498Methods and compositions for treating coronavirus infections
#499METHOD OF TREATING AND PREVENTING BONE AND JOINT INFECTIONS
#500B CELLS FOR IN VIVO DELIVERY OF THERAPEUTIC AGENTS AND DOSAGES THEREOF
#501COMPOSITION CONTAINING GLUCORAPHANIN AND USE THEREOF
#502Combination treatment for atopic dermatitis
#503Method of treating pathogenic bacterial infectious diseases
#504APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP
#505SUBCUTANEOUS TELOMERASE INHIBITOR COMPOSITIONS AND METHODS FOR USING SAME
#506Engineering of DNASE enzymes for manufacturing and therapy
#507Therapeutic agent for disc herniation
#508LYSINS AND DERIVATIVES THEREOF WITH BACTERICIDAL ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA, IN THE PRESENCE OF HUMAN SERUM
#509METHOD OF TREATING INFECTIVE ENDOCARDITIS
#510POLYNUCLEOTIDES
#511COMBINATION OF NASAL GENE DELIVERY AND ORAL CINNAMIC ACID, OLEAMIDE OR GEMFIBROZIL FOR LYSOSOMAL STOARGE DISORDERS
#512LYSOZYME HYDROLYSATE FOR PROACTIVE INHIBITORY CONTROL AND CONTROL OF IMPULSIVITY
#513MICROBIAL STRAINS FOR VIRUS INHIBITION
#514DYNAMIC COVALENTLY LINKED HYDROGELS AS STABILIZATION NETWORK PLATFORMS
#515TREATMENT OF SANFILIPPO SYNDROME TYPE B
#516Methods and compositions for CNS delivery of heparan N-sulfatase
#517HYALURONIDASE COMPOSITIONS AND METHODS OF USING SAME TO TREAT EDEMA
#518FEED ADDITIVE FORMULATION AND METHODS OF MAKING AND USING THE SAME
#519STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA
#520GLUCOCEREBROSIDASE POLYPEPTIDES
#521INJECTABLE COMPOSITION FOR INDUCING LIPOLYSIS AND METHOD USING THE SAME
#522RECOMBINANT ADENO-ASSOCIATED VIRUS COMPOSITIONS AND METHODS FOR PRODUCING SAME
#523COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MILK THISTLE EXTRACT OR POWDER
#524Microbial lysozyme for use in the treatment of irritable bowel syndrome or inflammatory bowel disease
#525Lipid nanoparticle compositions and methods for mRNA delivery
#526LIPID NANOPARTICLE COMPOSITIONS AND METHODS FOR MRNA DELIVERY
#527Lipid nanoparticle compositions and methods for MRNA delivery
#528COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS
#529Method of Treating Glycogen Storage Disease
#530CAPPED AND UNCAPPED RNA MOLECULES AND BLOCK COPOLYMERS FOR INTRACELLULAR DELIVERY OF RNA
#531Lipid nanoparticle compositions and methods for mRNA delivery
#532GLYCOENGINEERING IMMUNOGLOBULIN E
#533PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME
#534Selective recovery
#535METHOD FOR IMPROVING NEUROLOGICAL FUNCTION IN MPSI AND MPSII AND OTHER NEUROLOGICAL DISORDERS
#536SUBCUTANEOUS THERAPEUTIC ENZYME FORMULATIONS, USES, AND METHODS FOR GENERATING THEREOF
#537Engineered amylase variants
#538Stable Formulations of Programmed Death Receptor 1 (PD-1) Antibodies and Hyaluronidase Variants and Fragments Thereof and Methods of Use Thereof
#539Proteolytic enzyme composition
#540Food Supplement For Improving Sports Performance
#541Methods and gene therapy constructs for treating GM2 gangliosidoses
#542Anti inflammatory composition
#543METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE
#544Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
#545Recombinant Glycoproteins and Uses Thereof
#546STREPTOCOCCUS BACTERIOPHAGE LYSINS FOR DETECTION AND TREATMENT OF GRAM POSITIVE BACTERIA
#547EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#548Toner, Lysozyme Buccal Tablet and Preparation Method of Lysozyme Buccal Tablet
#549STABILIZED LIQUID ENZYME SUPPLEMENT AND USES THEREOF
#550mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
#551Methods and compositions for treating coronavirus infections
#552ANIMAL FEED COMPOSITIONS AND USES THEREOF
#553ANIMAL FEED COMPOSITION AND USE THEREOF
#554COMPOSITIONS AND METHODS FOR PROTECTING AGAINST AIRBORNE PATHOGENS AND IRRITANTS
#555Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses
#556Lipid nanoparticle compositions and methods for mRNA delivery
#557ANIMAL FEED COMPOSITIONS AND USES THEREOF
#558Feed additive composition
#559Methods and compositions for the treatment of cytoplasmic glycogen storage disorders
#560CHEWABLE TABLET
#561GENETICALLY MODIFIED MESENCHYMAL STEM CELL EXPRESSING KLOTHO
#562Conjugates of tumor necrosis factor inhibitors to functionalized polymers
#563ENHANCED THERAPEUTIC USAGE OF A PURINE NUCLEOSIDE PHOSPHORYLASE OR NUCELOSIDE HYDROLASE PRODRUG
#564CANCER TREATMENT
#565ANIMAL FEED COMPOSITION AND USE THEREOF
#566Disulfide bond stabilized polypeptide compositions and methods of use
#567BLOOD COMPONENT POTENTIATION OF LYTIC PROTEIN ANTI-BACTERIAL ACTIVITY AND METHODS AND USES THEREOF
#568METHODS FOR TREATING SYMPTOMS AND DISORDERS ASSOCIATED WITH LYSOSOMAL STORAGE DISEASES
#569Lysin Agent and Method of Use for Diagnostic Testing
#570FABRY DISEASE GENE THERAPY
#571METHODS FOR TREATING SYMPTOMS AND DISORDERS ASSOCIATED WITH LYSOSOMAL STORAGE DISEASES
#572FUSOSOME COMPOSITIONS FOR CNS DELIVERY
#573METHODS AND MATERIALS FOR REDUCING AGE-RELATED STRIATED MUSCLE AND COGNITIVE DECLINE
#574TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS INFECTION WITH KLOTHO
#575ANTI-PATHOGENIC ACTIVITY OF A BIFUNCTIONAL PEPTIDOGLYCAN/CHITIN HYDROLASE
#576Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38
#577METHODS AND COMPOSITIONS FOR INCREASING GALACTOSIDASE BETA-1 ACTIVITY IN THE CNS
#578MRNA therapy for pompe disease
#579Daratumumab and Hyaluronidase for the Treatment of Multiple Myeloma
#580Recombinant human acid alpha-glucosidase
#581CO-ADMINISTRATION OF A HYALURONIDASE AND ANTI-C5 ANTIBODY FOR TREATMENT OF COMPLEMENT-ASSOCIATED CONDITIONS
#582AN ANTIMICROBIAL COMPOSITION FOR SELECTIVELY INHIBITING GROWTH OF P. ACNES BACTERIA
#583Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D
#584Spherical agglomeration of proteins
#585Adeno-associated virus variant capsids and methods of use thereof
#586EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING
#587ADENO-ASSOCIATED VIRUS FOR THERAPEUTIC DELIVERY TO CENTRAL NERVOUS SYSTEM
#588Hyaluronidase for the prevention, treatment, reduction and/or abolishment of cerebral edema and intracranial pressure
#589Composition and/or combination for aquaculture
#590METHODS FOR USING ANTIMICROBIAL COMPOSITIONS
#591Reducing or inhibiting ocular damage by hyaluronidase administration
#592COMPOSITIONS AND METHODS FOR TREATING GM1 GANGLIOSIDOSIS AND OTHER DISORDERS
#593Subcutaneous anti-HER2 Antibody Formulations and Uses Thereof
#594CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS
#595Use of recombinant antibacterial protein Ablysin for effectively killing multidrug-resistant pathogenic bacteria
#596Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture
#597Chimeric bacteriophage lysin with activity against bacteria
#598ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM
#599Systems and methods for treating coronavirus
#600INHIBITION AND TREATMENT OF GASTROINTESTINAL BIOFILMS